Marc F Bolliger

Title: The Innovative Contributions of Marc F Bolliger

Introduction

Marc F Bolliger is a notable inventor based in Brittnau, Switzerland. He has made significant contributions to the field of neurobiology through his innovative research and inventions. His work focuses on understanding neurotrypsin inhibitors and their potential applications in treating various diseases.

Latest Patents

Marc F Bolliger holds a patent for a method for determining inhibitors of neurotrypsin. This invention relates to a method for determining whether a compound is a neurotrypsin inhibitor. The method is characterized by incubating the compound with neurotrypsin, a variant, or a fragment comprising the protease domain, along with a protein or peptide that includes agrin or its variants. The amount of cleavage of agrin is then measured in an aqueous buffer solution. This invention also identifies inhibitors of neurotrypsin, particularly compounds that can be used for the treatment and prophylaxis of diseases caused by synaptic deficiencies, such as skeletal muscle atrophy, schizophrenia, and cognitive disturbances.

Career Highlights

Marc F Bolliger is affiliated with the University of Zurich, where he continues to advance his research in neurobiology. His work has garnered attention for its potential impact on understanding and treating neurological disorders.

Collaborations

Throughout his career, Marc has collaborated with esteemed colleagues, including Peter Sonderegger and Stefan Hettwer. These collaborations have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Marc F Bolliger's innovative work in the field of neurobiology exemplifies the importance of research in developing treatments for complex neurological conditions. His contributions through patents and collaborations highlight the potential for scientific advancements to improve health outcomes.